Latest anticoagulants news
DOACs Cut Recurrent VTE in Adults With Cancer-Related Thrombosis
posted February 17th
by modernClinician Editorial Team
by modernClinician Editorial Team
NOACs May Be Better Choice for Patients With A-Fib and DM
posted February 14th
by modernClinician Editorial Team
by modernClinician Editorial Team
Bleeding Events Up With Full-Dose Thromboprophylaxis in COVID-19
posted February 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
Adding a P2Y12 Inhibitor Does Not Improve Outcomes in COVID-19
posted January 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2 
New Guideline Details Diagnosis, Treatment of Acute Pulmonary Embolism 
Continuing Oral Anticoagulants After ≥90 Days Tied to Lower Risk for Recurrent VTE 
Elevated INR in Older Adults on Warfarin May Not Be Tied to Risk for Brain Bleeding After Head Trauma 
Bleeding Risks for Oral Anticoagulants and Aspirin Mostly Similar 
Fewer Bleeding Events Seen With Abelacimab Than Rivaroxaban in A-Fib 
Therapeutic-Dose Anticoagulation Linked to Lower Mortality in COVID-19 Monthly Specialist Briefings
Stay Connected
